(+)-catechin multiple interactions ISO RGD:736644 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of FGFR4 mRNA CTD PMID:24763279 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:736645 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736645 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGFR4 mRNA CTD PMID:19770486 , PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736645 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 , PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736645 6480464 Tetrachlorodibenzodioxin affects the expression of FGFR4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGFR4 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FGFR4 mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of FGFR4 mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736645 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR4 mRNA CTD PMID:31009676 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of FGFR4 mRNA CTD PMID:19162173 4-hydroxyphenyl retinamide increases expression ISO RGD:736645 6480464 Fenretinide results in increased expression of FGFR4 mRNA CTD PMID:28973697 aflatoxin B1 affects expression ISO RGD:736644 6480464 Aflatoxin B1 affects the expression of FGFR4 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:736644 6480464 Aflatoxin B1 results in decreased methylation of FGFR4 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:736645 6480464 Aflatoxin B1 results in decreased expression of FGFR4 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:736644 6480464 Tretinoin results in decreased expression of FGFR4 mRNA CTD PMID:7680553 arsane decreases expression ISO RGD:736645 6480464 Arsenic results in decreased expression of FGFR4 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:736645 6480464 Arsenic results in decreased expression of FGFR4 mRNA CTD PMID:19654921 benomyl increases expression EXP 6480464 Benomyl results in increased expression of FGFR4 mRNA CTD PMID:15885261 benzo[a]pyrene decreases expression ISO RGD:736645 6480464 Benzo(a)pyrene results in decreased expression of FGFR4 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:736644 6480464 Benzo(a)pyrene results in decreased expression of FGFR4 mRNA CTD PMID:20106945 , PMID:21632981 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:736645 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FGFR4 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A affects expression ISO RGD:736644 6480464 bisphenol A affects the expression of FGFR4 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:736645 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FGFR4 gene CTD PMID:28505145 buta-1,3-diene decreases expression ISO RGD:736645 6480464 1, 3-butadiene results in decreased expression of FGFR4 mRNA CTD PMID:29038090 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of FGFR4 mRNA CTD PMID:19167457 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of FGFR4 gene CTD PMID:30521419 carbon nanotube decreases expression ISO RGD:736645 6480464 Nanotubes, Carbon analog results in decreased expression of FGFR4 mRNA, Nanotubes, Carbon results in decreased expression of FGFR4 mRNA CTD PMID:25554681 chloroprene decreases expression ISO RGD:736645 6480464 Chloroprene results in decreased expression of FGFR4 mRNA CTD PMID:23125180 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of FGFR4 mRNA CTD PMID:17589599 cholesterol affects metabolic processing ISO RGD:736645 6480464 FGFR4 protein affects the metabolism of Cholesterol CTD PMID:11956156 cholesterol decreases metabolic processing ISO RGD:736644 6480464 FGFR4 protein results in decreased metabolism of Cholesterol CTD PMID:15750181 chromium(6+) affects expression ISO RGD:736645 6480464 chromium hexavalent ion affects the expression of FGFR4 mRNA CTD PMID:28472532 cisplatin decreases expression ISO RGD:736644 6480464 Cisplatin results in decreased expression of FGFR4 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:736645 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FGFR4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FGFR4 mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:736645 6480464 Clofibrate results in decreased expression of FGFR4 mRNA CTD PMID:23811191 clofibric acid decreases expression EXP 6480464 Clofibric Acid results in decreased expression of FGFR4 mRNA CTD PMID:15833021 clofibric acid multiple interactions EXP 6480464 [Clofibric Acid co-treated with Diethylnitrosamine] results in decreased expression of FGFR4 mRNA CTD PMID:15833021 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FGFR4 mRNA CTD PMID:24386269 copper atom decreases expression EXP 6480464 Copper results in decreased expression of FGFR4 mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of FGFR4 mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:736644 6480464 Copper Sulfate results in decreased expression of FGFR4 mRNA CTD PMID:19549813 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of FGFR4 protein CTD PMID:15770714 cyclosporin A decreases expression ISO RGD:736644 6480464 Cyclosporine results in decreased expression of FGFR4 mRNA CTD PMID:20106945 more ... cyclosporin A decreases expression ISO RGD:736645 6480464 Cyclosporine results in decreased expression of FGFR4 mRNA CTD PMID:19770486 cyclosporin A multiple interactions EXP 6480464 [Thioacetamide co-treated with Cyclosporine] results in decreased expression of FGFR4 protein CTD PMID:15770714 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of FGFR4 mRNA CTD PMID:15885261 dexamethasone multiple interactions ISO RGD:736645 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR4 mRNA CTD PMID:31009676 dextran sulfate increases expression ISO RGD:736645 6480464 Dextran Sulfate results in increased expression of FGFR4 mRNA CTD PMID:27580383 diazinon increases expression EXP 6480464 Diazinon results in increased expression of FGFR4 mRNA CTD PMID:17589599 , PMID:19130878 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FGFR4 mRNA CTD PMID:21266533 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of FGFR4 mRNA CTD PMID:19130878 dioxygen multiple interactions ISO RGD:736645 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGFR4 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:736644 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR4 mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FGFR4 mRNA CTD PMID:29391264 ethanol increases expression EXP 6480464 Ethanol results in increased expression of FGFR4 mRNA CTD PMID:29769550 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of FGFR4 mRNA CTD PMID:28263823 flutamide increases expression EXP 6480464 Flutamide results in increased expression of FGFR4 mRNA CTD PMID:15885261 furosemide affects expression EXP 6480464 Furosemide affects the expression of FGFR4 mRNA CTD PMID:16526316 GW 4064 multiple interactions ISO RGD:736645 6480464 FGFR4 protein affects the reaction [[GW 4064 results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA] CTD PMID:22467244 heparan sulfate affects binding ISO RGD:736644 6480464 Heparitin Sulfate analog binds to FGFR4 protein CTD PMID:11278860 heparin affects binding ISO RGD:736644 6480464 Heparin analog binds to FGFR4 protein CTD PMID:11278860 heparin multiple interactions EXP 6480464 Heparin affects the reaction [FGF1 protein binds to FGFR4 protein], Heparin affects the reaction [FGF2 protein binds to FGFR4 protein] CTD PMID:10336501 heparin multiple interactions ISO RGD:736644 6480464 Heparin promotes the reaction [FGF19 protein binds to FGFR4 protein], Heparin promotes the reaction [FGFR4 protein binds to FGFR4 protein] CTD PMID:10525310 , PMID:10736564 lead diacetate decreases expression ISO RGD:736645 6480464 lead acetate results in decreased expression of FGFR4 mRNA CTD PMID:22609695 mono(2-ethylhexyl) phthalate increases expression ISO RGD:736645 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of FGFR4 mRNA CTD PMID:31009676 N-methyl-N-nitrosourea multiple interactions EXP 6480464 Methylnitrosourea results in increased expression of and affects the localization of FGFR4 protein CTD PMID:15581186 N-nitrosodiethylamine decreases response to substance ISO RGD:736645 6480464 FGFR4 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:19009564 N-nitrosodiethylamine multiple interactions EXP 6480464 [Clofibric Acid co-treated with Diethylnitrosamine] results in decreased expression of FGFR4 mRNA CTD PMID:15833021 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of FGFR4 mRNA CTD PMID:17032414 nickel atom affects expression EXP 6480464 Nickel affects the expression of FGFR4 mRNA CTD PMID:19130878 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FGFR4 mRNA CTD PMID:26720608 obeticholic acid decreases expression ISO RGD:736644 6480464 obeticholic acid results in decreased expression of FGFR4 mRNA CTD PMID:27939613 okadaic acid decreases phosphorylation ISO RGD:736645 6480464 Okadaic Acid results in decreased phosphorylation of FGFR4 protein CTD PMID:8576110 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of FGFR4 mRNA CTD PMID:27638505 paracetamol multiple interactions ISO RGD:736645 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FGFR4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FGFR4 mRNA] CTD PMID:17585979 paracetamol affects expression ISO RGD:736645 6480464 Acetaminophen affects the expression of FGFR4 mRNA CTD PMID:17562736 PD173074 multiple interactions ISO RGD:736644 6480464 PD 173074 inhibits the reaction [FGF1 protein results in increased phosphorylation of FGFR4 protein] CTD PMID:15709206 PD173074 decreases activity ISO RGD:736644 6480464 PD 173074 results in decreased activity of FGFR4 protein CTD PMID:15377668 perfluorooctane-1-sulfonic acid affects expression ISO RGD:736645 6480464 perfluorooctane sulfonic acid affects the expression of FGFR4 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:736645 6480464 perfluorooctanoic acid affects the expression of FGFR4 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:736644 6480464 perfluorooctanoic acid results in decreased expression of FGFR4 protein CTD PMID:26879310 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of FGFR4 mRNA CTD PMID:19162173 phenylmercury acetate decreases expression ISO RGD:736644 6480464 Phenylmercuric Acetate results in decreased expression of FGFR4 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736644 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR4 mRNA CTD PMID:27188386 phosgene affects expression ISO RGD:736645 6480464 Phosgene affects the expression of FGFR4 mRNA CTD PMID:16300373 pirinixic acid multiple interactions ISO RGD:736644 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FGFR4 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:736645 6480464 pirinixic acid results in decreased expression of FGFR4 mRNA CTD PMID:20813756 , PMID:23811191 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FGFR4 mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO RGD:736645 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of FGFR4 mRNA CTD PMID:20813756 ponatinib decreases activity ISO RGD:736644 6480464 ponatinib analog results in decreased activity of FGFR4 protein, ponatinib results in decreased activity of FGFR4 protein CTD PMID:19878872 , PMID:21561767 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:736645 6480464 Pregnenolone Carbonitrile results in decreased expression of FGFR4 mRNA CTD PMID:28903501 quercetin decreases expression ISO RGD:736644 6480464 Quercetin results in decreased expression of FGFR4 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:736644 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR4 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:736644 6480464 Silicon Dioxide analog results in decreased expression of FGFR4 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:736644 6480464 sodium arsenite results in increased expression of FGFR4 mRNA CTD PMID:12377979 sulindac sulfide decreases expression ISO RGD:736644 6480464 sulindac sulfide results in decreased expression of FGFR4 mRNA CTD PMID:16184548 taurocholic acid multiple interactions ISO RGD:736645 6480464 FGFR4 protein affects the reaction [Taurocholic Acid results in decreased expression of CYP7A1 mRNA], FGFR4 protein affects the reaction [Taurocholic Acid results in decreased expression of PON1 mRNA] CTD PMID:16284190 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FGFR4 mRNA CTD PMID:16644059 , PMID:17805973 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FGFR4 mRNA CTD PMID:17032414 tetrachloromethane decreases response to substance ISO RGD:736645 6480464 FGFR4 protein results in decreased susceptibility to Carbon Tetrachloride CTD PMID:12466116 thioacetamide multiple interactions EXP 6480464 [Thioacetamide co-treated with Cyclosporine] results in decreased expression of FGFR4 protein CTD PMID:15770714 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FGFR4 mRNA CTD PMID:23411599 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FGFR4 protein CTD PMID:15770714 titanium dioxide decreases expression ISO RGD:736645 6480464 titanium dioxide results in decreased expression of FGFR4 mRNA CTD PMID:27760801 valproic acid increases expression ISO RGD:736644 6480464 Valproic Acid results in increased expression of FGFR4 mRNA CTD PMID:28001369 zoledronic acid decreases expression ISO RGD:736644 6480464 zoledronic acid results in decreased expression of FGFR4 mRNA CTD PMID:24714768
Biological Process alveolar secondary septum development ISO RGD:736645 1624291 MGI:MGI:95524 (MGI:MGI:1309575 , PMID:9716527) RGD MGI:MGI:1309575 , PMID:9716527 cell migration ISO RGD:736644 1624291 (PMID:20876804) RGD PMID:20876804 cell migration ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cholesterol homeostasis ISS UniProtKB:Q03142 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cholesterol homeostasis ISO RGD:736645 1624291 (MGI:MGI:1858658, PMID:10809780) RGD MGI:MGI:1858658 , PMID:10809780 fibroblast growth factor receptor signaling pathway ISO RGD:736645 1624291 UniProtKB:O95750 more ... RGD MGI:MGI:4361675 , PMID:18187602 fibroblast growth factor receptor signaling pathway IPI UniProtKB:P15655 8553993 PMID:10766846 MGI fibroblast growth factor receptor signaling pathway IPI UniProtKB:O54796 8553993 PMID:10766846 MGI fibroblast growth factor receptor signaling pathway ISO RGD:736644 1624291 UniProtKB:O95750 more ... RGD PMID:10525310 more ... glucose homeostasis ISO RGD:736645 1624291 (MGI:MGI:3761543, PMID:17664243) RGD MGI:MGI:3761543 , PMID:17664243 glucose homeostasis ISS UniProtKB:Q03142 1600115 GO_REF:0000024 UniProt GO_REF:0000024 lung development ISO RGD:736645 1624291 (MGI:MGI:3511765, PMID:15576401) RGD MGI:MGI:3511765 , PMID:15576401 multicellular organism development IBA FB:FBgn0003733 more ... 13792537 PMID:21873635 GO_Central negative regulation of fibroblast growth factor production ISO RGD:736645 1624291 MGI:MGI:95522 (MGI:MGI:5548021 , PMID:24259513) RGD MGI:MGI:5548021 , PMID:24259513 negative regulation of gene expression ISO RGD:736645 1624291 MGI:MGI:95522 (MGI:MGI:5548021 , PMID:24259513) RGD MGI:MGI:5548021 , PMID:24259513 organ induction ISO RGD:736645 1624291 (MGI:MGI:3511765, PMID:15576401) RGD MGI:MGI:3511765 , PMID:15576401 peptidyl-tyrosine phosphorylation ISO RGD:736644 1624291 (PMID:18480409), (PMID:20683963) RGD PMID:18480409 , PMID:20683963 peptidyl-tyrosine phosphorylation ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 phosphate ion homeostasis ISO RGD:736645 1624291 (MGI:MGI:5285060, PMID:21561999) RGD MGI:MGI:5285060 , PMID:21561999 phosphate ion homeostasis ISS UniProtKB:Q03142 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of catalytic activity ISO RGD:736644 1624291 (PMID:20798051) RGD PMID:20798051 positive regulation of catalytic activity ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of cell population proliferation ISO RGD:736645 1624291 UniProtKB:O95750 more ... RGD MGI:MGI:4361675 , PMID:18187602 positive regulation of cell population proliferation ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of cell population proliferation ISO RGD:736644 1624291 UniProtKB:P05230 more ... RGD PMID:8663044 positive regulation of DNA biosynthetic process ISO RGD:736644 1624291 (PMID:21653700) RGD PMID:21653700 positive regulation of DNA biosynthetic process ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of ERK1 and ERK2 cascade ISO RGD:736644 1624291 (PMID:21653700) RGD PMID:21653700 positive regulation of ERK1 and ERK2 cascade IBA PANTHER:PTN004704289 , UniProtKB:P22455 13792537 PMID:21873635 GO_Central positive regulation of ERK1 and ERK2 cascade ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of gene expression ISO RGD:736644 1624291 (PMID:19085950) RGD PMID:19085950 positive regulation of kinase activity IBA PANTHER:PTN001230349 , UniProtKB:Q16832 13792537 PMID:21873635 GO_Central positive regulation of parathyroid hormone secretion ISO RGD:736645 1624291 MGI:MGI:95522 (MGI:MGI:5548021 , PMID:24259513) RGD MGI:MGI:5548021 , PMID:24259513 positive regulation of proteolysis ISO RGD:736644 1624291 (PMID:20798051) RGD PMID:20798051 positive regulation of proteolysis ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein autophosphorylation ISO RGD:736644 1624291 (PMID:20798051) RGD PMID:20798051 protein autophosphorylation ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of bile acid biosynthetic process ISO RGD:736644 1624291 (PMID:17623664), (PMID:20683963) RGD PMID:17623664 , PMID:20683963 regulation of bile acid biosynthetic process IBA MGI:MGI:95525 more ... 13792537 PMID:21873635 GO_Central regulation of bile acid biosynthetic process ISS UniProtKB:Q03142 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of bile acid biosynthetic process ISO RGD:736645 1624291 (MGI:MGI:1858658, PMID:10809780) RGD MGI:MGI:1858658 , PMID:10809780 regulation of extracellular matrix disassembly ISO RGD:736644 1624291 (PMID:20876804) RGD PMID:20876804 regulation of extracellular matrix disassembly ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of lipid metabolic process ISO RGD:736645 1624291 (MGI:MGI:3761543, PMID:17664243) RGD MGI:MGI:3761543 , PMID:17664243 regulation of lipid metabolic process ISS UniProtKB:Q03142 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of phosphate transport ISO RGD:736645 1624291 MGI:MGI:95522 (MGI:MGI:5548021 , PMID:24259513) RGD MGI:MGI:5548021 , PMID:24259513 regulation of phosphorus metabolic process ISO RGD:736645 1624291 MGI:MGI:95522 (MGI:MGI:5548021 , PMID:24259513) RGD MGI:MGI:5548021 , PMID:24259513 response to bile acid NOT ISO RGD:736644 1624291 (PMID:19085950) RGD PMID:19085950 transmembrane receptor protein tyrosine kinase signaling pathway IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central vitamin D3 metabolic process ISO RGD:736645 1624291 MGI:MGI:95522 (MGI:MGI:5548021 , PMID:24259513) RGD MGI:MGI:5548021 , PMID:24259513 Cellular Component cell-cell junction colocalizes_with ISO RGD:736644 1624291 (PMID:20798051) RGD PMID:20798051 cell-cell junction colocalizes_with ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 endoplasmic reticulum ISO RGD:736644 1624291 (PMID:20683963) RGD PMID:20683963 endoplasmic reticulum ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 endosome IEA UniProtKB-SubCell:SL-0101 1600115 GO_REF:0000044 UniProt GO_REF:0000044 Golgi apparatus ISO RGD:736644 1624291 (PMID:18061161) RGD PMID:18061161 integral component of plasma membrane ISO RGD:736644 1624291 (PMID:20683963) RGD PMID:20683963 integral component of plasma membrane IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central integral component of plasma membrane ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 plasma membrane ISO RGD:736644 1624291 (PMID:18061161) RGD PMID:18061161 receptor complex IBA FB:FBgn0015380 more ... 13792537 PMID:21873635 GO_Central transport vesicle ISO RGD:736644 1624291 (PMID:18061161) RGD PMID:18061161 Molecular Function ATP binding IEA UniProtKB-KW:KW-0067 1600115 GO_REF:0000043 UniProt GO_REF:0000043 fibroblast growth factor binding ISO RGD:736644 1624291 UniProtKB:O95750 (PMID:10525310), (PMID:17627937), (PMID:18480409), (PMID:8663044) RGD PMID:10525310 more ... fibroblast growth factor binding IBA MGI:MGI:95522 more ... 13792537 PMID:21873635 GO_Central fibroblast growth factor binding ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 fibroblast growth factor-activated receptor activity ISO RGD:736644 1624291 UniProtKB:O95750 (PMID:10525310), (PMID:18480409), (PMID:21653700), (PMID:8663044) RGD PMID:10525310 more ... fibroblast growth factor-activated receptor activity IBA MGI:MGI:95522 more ... 13792537 PMID:21873635 GO_Central heparin binding ISO RGD:736644 1624291 (PMID:18480409) RGD PMID:18480409 heparin binding ISS UniProtKB:P22455 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein binding ISO RGD:736644 1624291 UniProtKB:P50281 , UniProtKB:Q86Z14 (PMID:17627937), (PMID:20798051) RGD PMID:17627937 , PMID:20798051 protein binding ISO RGD:736645 1624291 PR:O35082 more ... RGD MGI:MGI:3640642 more ... transmembrane receptor protein tyrosine kinase activity IBA FB:FBgn0003366 more ... 13792537 PMID:21873635 GO_Central
Gene-Chemical Interaction Annotations
